CD274 and small cell lung carcinoma: The CAPSTONE-1 clinical trial rigorously evaluated the therapeutic efficacy and safety profile of adebrelimab, an anti-PD-L1 monoclonal antibody, when conjoined with standard chemotherapy regimens for initial treatment in patients diagnosed with ES-SCLC.